0
     

Report Added
Report already added
North America DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity

North America DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity

North America DNA sequencing market is projected to grow by 14.8% annually in the forecast period and reach $20,330.9 million by 2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.

Highlighted with 22 tables and 53 figures, this 102-page report “North America DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country.

Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Sequencing Services

Based on Sequencing Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sanger Sequencing
•Next Generation Sequencing
•Other Sequencing Types

By Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sequencing by Synthesis
•Ion Semiconductor Sequencing
•Chain Termination Sequencing
•Pyrosequencing
•Sequencing by Ligation (SBL)
•Single-Molecule Real-Time Sequencing (SMRT)
•Nanopore Sequencing
•Other Technologies

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Biomarker Discovery
•Diagnostics
•Personalized Medicine
•Reproductive Health
•Forensics
•Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Academics and Research Organizations
•Pharmaceutical and Biotechnology Companies
•Hospitals & Clinics
•Other End Users

Geographically, the following national/local markets are fully investigated:
•U.S.
•Canada
•Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Sequencing Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market22
2.2 Major Growth Drivers24
2.3 Market Restraints and Challenges31
2.4 Emerging Opportunities and Market Trends34
2.5 Porter’s Fiver Forces Analysis38
3 Segmentation of North America Market by Offering42
3.1 Market Overview by Offering42
3.2 Instruments44
3.3 Consumables45
3.4 Sequencing Services46
4 Segmentation of North America Market by Sequencing Type47
4.1 Market Overview by Sequencing Type47
4.2 Sanger Sequencing49
4.3 Next Generation Sequencing50
4.4 Other Sequencing Types51
5 Segmentation of North America Market by Technology52
5.1 Market Overview by Technology52
5.2 Sequencing by Synthesis54
5.3 Ion Semiconductor Sequencing55
5.4 Chain Termination Sequencing56
5.5 Pyrosequencing57
5.6 Sequencing by Ligation (SBL)58
5.7 Single-Molecule Real-Time Sequencing (SMRT)59
5.8 Nanopore Sequencing60
5.9 Other Technologies61
6 Segmentation of North America Market by Application62
6.1 Market Overview by Application62
6.2 Biomarker Discovery64
6.3 Diagnostics65
6.4 Personalized Medicine66
6.5 Reproductive Health67
6.6 Forensics68
6.7 Other Applications69
7 Segmentation of North America Market by End User70
7.1 Market Overview by End User70
7.2 Academics and Research Organizations72
7.3 Pharmaceutical and Biotechnology Companies73
7.4 Hospitals & Clinics74
7.5 Other End Users75
8 North America Market 2021-2031 by Country76
8.1 Overview of North America Market76
8.2 U.S.79
8.3 Canada82
8.4 Mexico84
9 Competitive Landscape86
9.1 Overview of Key Vendors86
9.2 New Product Launch, Partnership, Investment, and M&A89
9.3 Company Profiles90
Agilent Technologies Inc.90
BGI Genomics Co., Ltd.92
Bio-Rad Laboratories Inc.93
Danaher Corporation (Integrated DNA Technologies Inc.)94
Eurofins Scientific SE95
F. Hoffmann-La Roche Ltd.96
Illumina Inc.97
Merck KGaA98
Pacific Biosciences of California Inc.99
PerkinElmer Inc.100
Thermo Fisher Scientific Inc.101
RELATED REPORTS102

List of Tables:

Table 1. Snapshot of North America DNA Sequencing Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Health Spending by Region, $ bn, 2013-202030
Table 4. Main Product Trends and Market Opportunities in North America DNA Sequencing Market34
Table 5. North America DNA Sequencing Market by Offering, 2021-2031, $ mn42
Table 6. North America DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn47
Table 7. North America DNA Sequencing Market by Technology, 2021-2031, $ mn52
Table 8. North America DNA Sequencing Market by Application, 2021-2031, $ mn62
Table 9. North America DNA Sequencing Market by End User, 2021-2031, $ mn70
Table 10. North America DNA Sequencing Market by Country, 2021-2031, $ mn77
Table 11. U.S. DNA Sequencing Market by Offering, 2021-2031, $ mn81
Table 12. U.S. DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn81
Table 13. U.S. DNA Sequencing Market by End User, 2021-2031, $ mn81
Table 14. Canada DNA Sequencing Market by Offering, 2021-2031, $ mn83
Table 15. Canada DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn83
Table 16. Canada DNA Sequencing Market by End User, 2021-2031, $ mn83
Table 17. Mexico DNA Sequencing Market by Offering, 2021-2031, $ mn85
Table 18. Mexico DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn85
Table 19. Mexico DNA Sequencing Market by End User, 2021-2031, $ mn85
Table 20. Agilent Technologies Inc.: Company Snapshot90
Table 21. Agilent Technologies Inc.: Business Segmentation91
Table 22. Agilent Technologies Inc.: Product Portfolio91

Report Title: North America DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline